Regulus (RGLS) Cash Money per Share

Symbol and logo of brand Regulus (RGLS)

Combating rare nephrological pathologies requires alliances with pharma behemoths, which is reflected in the cash per share reserves of Regulus Therapeutics (RGLS). The value of 0.94 expresses the metric level, confirming liquidity for R&D. Fixed costs for RNA drugs will create powerful leverage following FDA approval, while operations remain strictly limited by medical regulations regarding the disposal of biomaterials.

RGLS Regulus Therapeutics Inc.: Cash per Single Share in the range 07/04/2022 - 07/05/2025

Comprehensive metric breakdowns and analytics for Regulus Therapeutics, Inc. (RGLS)

- price and consensus price forecast:
- cash and cash flow data:
Summary company analysis:RGLS Regulus
Finished products of Regulus Therapeutics Inc.

Cash per share determines the portion of liquid assets attributable to a single security, serving as a baseline for capital protection. For Regulus Therapeutics (RGLS), this resource is critical for funding clinical trials of RNA therapies for kidney diseases. The trend in cash per share reflects the burn rate of the budget allocated to pipeline development. A stable balance confirms the issuer's solvency prior to securing partnerships with pharma behemoths. This indicator provides an objective assessment of the company's financial cushion.

Analysis of competing companies

TEM (Tempus AI Inc) - Cash Calculated per Single Share|Cash per Share QGEN|IONS - Cash on Hand per Share|Cash Funds per Share Repligen RGEN|RNA: Cash Funds per Single Share|CRSP: Cash per Single Share|GeneDx Corp (WGS) - Cash per Single Share|RARE: Cash per Share|BEAM - Cash Funds Calculated per Share|SRPT (Sarepta Therapeutics) - Cash per Share|Cash per Single Share Twist Bioscience Inc (TWST)|Cash per Share TXG|Cash Funds Calculated per Share Intellia|Stoke - Cash per Single Share|BLFS: Cash Funds per Single Share|Wave Life Sciences Corp - Cash per Share|Maze Therapeutics, Inc. (MAZE) - Cash per Single Share|Sionna Therapeutics Inc (SION) - Cash Funds per Share|Cash per Single Share Prime Medicine Corp|Cash Funds per Share tayshagtx.com|QURE - Cash Funds Volume per Share|Cash per Single Share MGTX (MeiraGTx Holdings plc)|REGENXBIO (RGNX) - Cash Funds Volume per Share|Cash per Share SLDB (Solid Biosciences Inc.)|Amount of Cash per Share OCGN|PacBio Corp - Cash per Share|Benitec Biopharma Inc. (BNTC) - Cash per Single Share|DSGN: Cash per Share|Cash Funds per Single Share RCKT|Cash per Single Share FDMT|Cash Funds per Single Share LXEO (Lexeo Therapeutics)|Cash per Share KRRO|Editas Medicine, Inc. - Cash Funds per Single Share|Cash Funds per Share Silence Therapeutics Inc. SLN|Cash per Share ProQR Therapeutics N.V. PRQR|CDXS: Cash per Single Share|Cash Funds Volume per Share Sangamo (SGMO)|NAUT (Nautilus Bio) - Cash per Single Share|MGX - Cash Funds Calculated per Share|DTIL (Precision BioSciences Inc.) - Cash per Share|generationbio.com (GBIO) - Cash Funds Calculated per Share|Cash Funds per Share Boundless Bio Inc (BOLD)|Cash per Share Exicure Inc. (XCUR)|Cash Funds per Share imunon.com IMNN|Cash per Share Phio Pharmaceuticals PHIO|Mustang Bio Inc - Cash per Share|Cash on Hand per Share transcodetherapeutics.com|BNGO: Cash per Share|Cash Funds per Single Share APDN|BLUE (bluebirdbio.com) - Cash per Share|Cash on Hand per Share ImmunoPrecise Antibodies IPA|Cash per Single Share OMGA (omegatherapeutics.com)|Cash per Share Singular Genomics Systems, Inc. (OMIC)|Cash per Share SYRS (Syros Pharmaceuticals Inc.)|Cash Calculated per Single Share TBIO (Codex DNA)|TCON - Cash Funds per Share|Cash on Hand per Share Unity Biotechnology